Endomagnetics wins ACES award for most successful university spinout
23 February 2012
Cambridge, UK. Endomagnetics and one of its founders, Prof.
Quentin Pankhurst, Professor Physics at University College London, has
picked up a major technology business accolade by being recognised in
the Science Business Innovation Board, Academic Enterprise Awards
The company picked up the Life Sciences Award, given to the most
successful university spin-out company.
Endomagnetics is developing advanced magnetic sensing technology for
use in breast cancer staging, based on technology developed between
University College London and at the University of Houston.
success came in the face of stiff competition from companies in
several sectors and countries in Europe. The ACES judges took into
account the novelty of the research, clear evidence of commercial
success and the potential impact on society. Endomagnetics’ magnetic
technology can significantly extend the availability of sentinel
lymph node biopsy (SLNB), currently the standard of care in tracking
the spread of breast cancer.
The awards were announced at The European Entrepreneurship Summit
in Brussels this week. The ACES, run by The Science Business
Innovation Board and now in their fourth year, are the only
pan-European awards for enterprise from university and public
research institutes. They are intended to foster a culture of
enterprise among researchers.
Collecting the Life Sciences Award on behalf of Endomagnetics,
Professor Pankhurst, CTO, said: “We are naturally thrilled at our
work being selected for this award. We are especially delighted at
recognition of the huge potential for magnetic nanotechnology to
improve procedures and outcomes for clinicians and patients alike.”
For more information on the awards see